PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas

Soft-tissue sarcomas (STS) are a group of rare, heterogeneous, and aggressive tumors, with high metastatic risk and relatively few efficient systemic therapies. In the quest for new treatments, the immune system represents an attractive therapeutic target. Recently, PD1/PDL1 inhibitors showed very p...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncoimmunology
Main Authors: Bertucci, François, Finetti, Pascal, Perrot, Delphine, Leroux, Agnès, Collin, Françoise, Le Cesne, Axel, Coindre, Jean-Michel, Blay, Jean-Yves, Birnbaum, Daniel, Mamessier, Emilie
格式: Artigo
語言:Inglês
出版: Taylor & Francis 2017
主題:
Original Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5384364/
https://ncbi.nlm.nih.gov/pubmed/28405501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1278100
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍